Psychotropic Medication Use in French Children and Adolescents

Kovess, Viviane; Choppin, Sabine; Gao, Fei; Pivette, Mathilde; Husky, Mathilde M.; Leray, Emmanuelle

doi:10.1089/cap.2014.0058

Cited by 28 publications

(30 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…As reported in various previous studies the prevalence rates in the last years for psychotropic consumption in children and adolescents shows a trend to increase [2][3][4][5][6]12], but not in Catalonia were we find a decrease in their consumption. In Catalonia the prevalence of psychotropic use is lower than in the Nordic countries which is also shown in other South European countries as Italy and France [3,6]. In a French study analysing the patterns of consumption in children of 6-17 years there was an increase of 3.9% in antidepressants from 2009-2016 meanwhile in our study from 2009-2016 their consumption decreases in Catalonia (-7.7%) [13].…”

Section: Discussionsupporting

confidence: 60%

“…Consumption of psychotropic medication has been studied in the paediatric population (children and adolescents, < 18) in Europe [2][3][4][5][6][7]. Although, there is a large variation in the consumption of psychotropic medication at an international level in the paediatric population, this may be related to, and influenced by, multiple factors such as the cultural approach of each country towards mental diseases, the clinical practice or the health systems and health policy [8,9].…”

Section: Introductionmentioning

confidence: 99%

“…In Italy, the incidence of psychotropic new prescriptions in children under 18 years showed a decrease in the incidence from 2006 to 2011 (from 1.15 to 1.03/1,000 children) [6]. In France, children under 17 random sampled from the French National Health Insurance (CNAM) showed that 2.5% had a psychotropic drug prescription in 2010, mostly anxiolytics (1.9%) and minority stimulants (0.2%) [3].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Psychotropic use in children and adolescents in Scandinavia and Catalonia: a 10 years population-based study.

Gómez-Lumbreras

García-Sangenís²,

Vallverdú³

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: Psychotropic drugs have not been deeply studied in the paediatric population as normally this population is not included in clinical trials and these drugs are not authorised for it use in under 18 years. Objectives: To describe the use of psychotropic drugs in children and adolescents in the North of Europe and Catalonia. Methods: Data on psychotropic drug consumption in children and adolescents were retrieved from the databases of Catalonia, Denmark, Norway, and Sweden from 2008 to 2017. Psychotropic drugs were divided in antipsychotics, anxiolytics (also hypnotics and sedatives), antidepressants and psychostimulants. Data were stratified by group of age (0-4, 5-9, 10-14 and 15-19/ 15-17 for Denmark and Catalonia) and sex. Results: Overall the group of anxiolytics shows the highest consumption and the group of antipsychotics the lowest. Sweden is the country with the highest consumption of psychotropic drugs and the highest increase in its consumption. Denmark has the lowest consumption for all groups. Catalonia shows a decrease in psychotropic drugs. Girls consume more than twice as many antidepressants as boys and the opposite is for psychostimulants. Risperidone and quetiapine are among the most consumed antipsychotics in the Nordic countries, in Catalonia they are risperidone and aripiprazole. Among the antidepressants sertraline is the most consumed. No differences are found among the psychostimulants. Differences regarding the use of anxiolytics, hypnotics and sedatives are found between the Nordic countries (melatonin is the most consumed) and Catalonia (hydroxyzine). Conclusions: Psychotropic consumption in younger populations is increasing though there are differences among the active substances among countries. Nordic countries show a higher prevalence of use than Catalonia. Psychotropic drug consumption increases with age being the only exception the psychostimulants consumption, which is highest in the 10-14 years group.

show abstract

Section: Discussionsupporting

confidence: 60%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Psychotropic use in children and adolescents in Scandinavia and Catalonia: a 10 years population-based study.

Gómez-Lumbreras

García-Sangenís²,

Vallverdú³

et al. 2020

Preprint

View full text Add to dashboard Cite

show abstract

“…The use of stimulants to treat ADHD has increased markedly over the past two decades throughout the entire Western world . Nevertheless, stimulant use varies markedly between countries and regions of the world, with some countries such as France and Italy reporting as little as 0.2% and 0.02% of their paediatric population receiving pharmacological treatment . Some of the differences may be due to limited access to ADHD drugs or differences in preferring behavioural therapy with and without concomitant pharmacological treatment in some countries.…”

mentioning

confidence: 99%

Utilization of Stimulants and Atomoxetine for Attention‐Deficit/Hyperactivity Disorder among 5.4 Million Children Using Population‐Based Longitudinal Data

Furu

Karlstad

Zoëga

et al. 2017

Basic Clin Pharma Tox

View full text Add to dashboard Cite

Use of stimulants to treat attention-deficit/hyperactivity disorder (ADHD) has increased over the past two decades and varies substantially between countries. The objective of this multinational population-based study was to examine utilization of ADHD drugs (stimulants and atomoxetine) including comedication with other psychotropic drugs in the entire child population in the five Nordic countries. We included longitudinal data on dispensed ADHD drugs from five Nordic prescription registers during 2008-2012, which in 2012 comprised 48,296 individuals among 5.42 million inhabitants aged 0-17 years. Prevalence of filling ≥1 prescriptions of ADHD drugs among children aged 6-17 years increased during 2008-2012 from 5.9 to 11.2 and 19.4 to 31.0 per 1000 girls and boys, respectively. Prevalence by country showed that Iceland, Finland and Sweden had a steady increase during the study period, while in Norway the prevalence was quite stable and in Denmark it levelled off from 2010. Use in preschoolers (aged 0-5 years) was rare. Iceland had much higher prevalence and incidence than the other Nordic countries. The incidence of ADHD drug use increased during the study period, from 4.0 to 4.9 and from 1.5 to 2.3 per 1000 boys and girls, respectively. The increasing number of new users levelled off somewhat after 2010. Comedication with other psychotropic drugs was more common among girls (33.9%) than boys (27.0%) and was mainly melatonin, followed by antidepressants and antipsychotics. Overall prevalence of ADHD drug use increased among Nordic girls and boys aged 6-17 years, whereas the incidence increased slightly during 2008-2010 but levelled off through 2012. The substantial differences in ADHD drug use across the Nordic countries and high degree of comedication with other psychotropic drugs underscore the importance of close monitoring of treatment for ADHD among children.

show abstract

“…Par contre, la prévalence serait la plus élevée en France pour les hypnotiques et anxiolytiques (2 % vs moins de 1 % pour les autres pays) [17]. Cette tendance est corroborée par d'autres auteurs qui s'intéressent également au sujet en France [18,19] comme à l'étranger [20,21].…”

Section: Article In Pressunclassified

Les psychotropes chez l’adolescent : étude des prescriptions dans une unité de crise pour adolescents et documentation du hors AMM

Egron

Kompe-Tchamgoue

Malet

et al. 2016

Neuropsychiatrie de l'Enfance et de l'Adolescence

View full text Add to dashboard Cite

Psychotropic Medication Use in French Children and Adolescents

Cited by 28 publications

References 37 publications

Psychotropic use in children and adolescents in Scandinavia and Catalonia: a 10 years population-based study.

Psychotropic use in children and adolescents in Scandinavia and Catalonia: a 10 years population-based study.

Utilization of Stimulants and Atomoxetine for Attention‐Deficit/Hyperactivity Disorder among 5.4 Million Children Using Population‐Based Longitudinal Data

Les psychotropes chez l’adolescent : étude des prescriptions dans une unité de crise pour adolescents et documentation du hors AMM

Contact Info

Product

Resources

About